BCM
CELG

Bienville Capital Management’s Celgene Corp CELG Stock Holding History

Bienville Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,500
Closed -$392K – 110
2014
Q4 		$392K Buy
+3,500
New +$369K 0.32% 48

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bienville Capital Management's CELG Position: Q1 2015 in Review

Bienville Capital Management sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 3,500 shares — an estimated $392K sold.

Bienville Capital Management first reported a position in CELG in Q4 2014 and held it in 1 quarter. The position peaked at $392K in Q4 2014. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • Bienville Capital Management reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
  • Bienville Capital Management sold 3,500 Celgene Corp shares in Q1 2015, an estimated $392K.
  • Bienville Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 1 quarter.
  • Bienville Capital Management's Celgene Corp position peaked at $392K in Q4 2014.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Bienville Capital Management's 13F filing for Q1 2015, filed 13 May 2015.